brolucizumab
Drug Details
- Generic Name
- brolucizumab
- Brand Names
- BEOVU
- Application Number
- BLA761125
- Sponsor
- Novartis Pharmaceuticals Corporation
- NDC Codes
- 1
- Dosage Forms
- INJECTION, SOLUTION
- Routes
- INTRAVITREAL
- Active Ingredients
- BROLUCIZUMAB
Indications and Usage
1 INDICATIONS AND USAGE BEOVU ® is indicated for the treatment of: BEOVU is a human vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of: Neovascular (Wet) Age-Related Macular Degeneration (AMD) ( 1.1 ) Diabetic Macular Edema (DME) ( 1.2 ) 1.1 Neovascular (Wet) Age-related Macular Degeneration (AMD) 1.2 Diabetic Macular Edema (DME)